XML 29 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Oct. 01, 2016
Oct. 03, 2015
Cash Flows From Operating Activities    
Net loss $ (781,432) $ (1,344,423)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of leasehold improvements and equipment 234,408 209,754
Amortization of intangibles 63,116 32,236
Share-based compensation expense 930,026 1,656,504
Allowance for doubtful trade receivables 235,591 5,429
Loss from disposal of equipment 0 19,643
Loss on debt extinguishment 313,099 0
Non-cash financing costs 94,080 139,780
Changes in operating assets and liabilities:    
Trade receivables (4,296,439) (1,883,261)
Inventories 1,840,572 (429,287)
Prepaid expenses and other assets (230,667) (86,183)
Accounts payable (2,125,180) 108,961
Accrued expenses 406,797 361,481
Customer deposits and other 5,613 2,393
Deferred rent 182,634 (50,589)
Net cash used in operating activities (3,127,782) (1,257,562)
Cash Flows From Investing Activities    
Purchases of leasehold improvements and equipment (940,978) (242,765)
Purchases of intangible assets (205,000) (107,500)
Net cash used in investing activities (1,145,978) (350,265)
Cash Flows From Financing Activities    
Proceeds from issuance of common stock, net of issuance costs 5,717,474 0
Proceeds from exercise of stock options 716,612 25,266
Proceeds from loan payable 0 2,500,000
Payment of debt issuance cost 0 (15,000)
Principal payments on loan payable (5,000,000) 0
Cash paid for debt extinguishment costs (281,092) 0
Principal payments on capital leases (164,150) (158,547)
Net cash provided by financing activities 988,844 2,351,719
Net (decrease) increase in cash (3,284,916) 743,892
Cash Beginning of Period 5,549,672 3,964,750
Cash Ending of Period 2,264,756 4,708,642
Supplemental Disclosures of Cash Flow Information    
Cash payments for interest 251,231 293,968
Supplemental Schedule of Noncash Investing Activity    
Capital lease obligation incurred for purchases of equipment 0 303,933
Inventory supplied to Healthspan Research, LLC for equity interest, at cost 20,318 0
Retirement of fully depreciated equipment - cost 28,083 8,181
Retirement of fully depreciated equipment - accumulated depreciation $ (28,083) $ (8,181)